Facilitating Motor Skill Learning in Parkinson's Disease
Trial
N/A
Completed
Oct. 23, 2018
The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Parkinson's Disease
Trial
N/A
Completed
Oct. 23, 2018
Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease
Trial
N/A
Completed
Oct. 22, 2018
Autocorrelated Rhythmic Auditory Stimulations for Parkinson's Disease Patients
Trial
N/A
Completed
Oct. 22, 2018
The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD
Trial
N/A
Unknown
Oct. 22, 2018
Long- Term Transcranial Direct Current Stimulation in Parkinson's Disease
Trial
Phase 2
Unknown
Oct. 18, 2018
Autologous Stem/Stromal Cells in Neurological Disorders and Disease
Trial
N/A
Unknown
Oct. 17, 2018
Gut Microbiota and Parkinson's Disease
Trial
N/A
Unknown
Oct. 17, 2018
Efficacy and Safety of Opicapone in Clinical Practice
Trial
Phase 4
Completed
Oct. 14, 2018
Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone
Trial
Phase 1
Completed
Oct. 14, 2018
Nigrosomal Iron Imaging in Parkinson's Disease
Trial
N/A
Unknown
Oct. 11, 2018
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)
Trial
Phase 2
Completed
Oct. 10, 2018
Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease Patients
Trial
Phase 2
Completed
Oct. 9, 2018
Varenicline Treatment for Excessive Daytime Sleepiness in Parkinson's Disease
Trial
Phase 4
Terminated
Oct. 8, 2018
Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease
Trial
Phase 4
Terminated
Oct. 8, 2018
Evaluation of the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
Trial
Phase 3
Terminated
Oct. 4, 2018
Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism
Trial
Phase 2
Completed
Oct. 2, 2018
Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients
Trial
N/A
Completed
Oct. 1, 2018
A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)
Trial
Phase 1
Completed
Oct. 1, 2018